OrthoPediatrics Corp. Files 8-K on Financials
Ticker: KIDS · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1425450
| Field | Detail |
|---|---|
| Company | Orthopediatrics Corp (KIDS) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00025 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: KIDS
TL;DR
OrthoPediatrics (KIDS) filed an 8-K on Aug 5th detailing financial results and condition.
AI Summary
OrthoPediatrics Corp. filed an 8-K on August 5, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing pertains to the company's operations and financial reporting, with its common stock trading under the ticker KIDS on the Nasdaq exchange.
Why It Matters
This 8-K filing provides investors with crucial updates on OrthoPediatrics Corp.'s financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not inherently introduce new risks.
Key Players & Entities
- OrthoPediatrics Corp. (company) — Registrant
- KIDS (company) — Trading Symbol
- Nasdaq (company) — Exchange
- August 5, 2024 (date) — Filing Date
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed with the SEC?
The 8-K was filed on August 5, 2024.
What is the trading symbol for OrthoPediatrics Corp. common stock?
The trading symbol for OrthoPediatrics Corp. common stock is KIDS.
On which exchange is OrthoPediatrics Corp. common stock traded?
OrthoPediatrics Corp. common stock is traded on the Nasdaq exchange.
What is the principal executive office address for OrthoPediatrics Corp.?
The principal executive offices are located at 2850 Frontier Drive, Warsaw, Indiana 46582.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-08-05 17:09:51
Key Financial Figures
- $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global
Filing Documents
- kids-20240805.htm (8-K) — 27KB
- kidsq22024earningsrelease.htm (EX-99.1) — 214KB
- footer.jpg (GRAPHIC) — 17KB
- header.jpg (GRAPHIC) — 12KB
- logo.jpg (GRAPHIC) — 67KB
- 0001425450-24-000077.txt ( ) — 496KB
- kids-20240805.xsd (EX-101.SCH) — 2KB
- kids-20240805_lab.xml (EX-101.LAB) — 21KB
- kids-20240805_pre.xml (EX-101.PRE) — 12KB
- kids-20240805_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 5, 2024, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended June 30, 2024 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended June 30, 2024, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated August 5 , 2024 issued by OrthoPediatrics Corp. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: August 5, 2024 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 2 -